Congressional Briefing: Cost and Value of Prescription Meds
On Thursday, July 13, the Biotechnology Innovation Organization, along with other health organizations, co-hosted a congressional briefing at the House of Representatives in Washington, DC. A. Mark Fendrick, MD, presented on value-based pricing and cost-sharing for prescription drugs. Click here.
Catalyst for Payment Reform Interview
Catalyst for Payment Reform recently interviewed V-BID Center Director Mark Fendrick to discuss the premise of value-based insurance design programs, their future role in HSA-eligible High Deductible Health Plans, and how V-BID policies will begin to cover certain chronic conditions. Find the blog post and audio interview here.
Employee Benefit Research Institute Policy Forum
On July 12, the Employee Benefit Research Institute held its 81st policy forum examining the latest research on HSA-eligible health plans. V-BID Center Director Dr. A. Mark Fendrick presentation and other resources on expanding HSA enrollment by enhancing HSA-eligible health plans can be found here.
Alliance for Health Policy Health Care Summit
Dr. Mark Fendrick spoke at the Alliance for Health Policy Summit in Washington, D.C. on the coverage of chronic care. Read more.